Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Universal Framework for Blood Ionome Extraction and Intelligent Quality Control in <sup>1</sup>H NMR Metabolomics.

Analytical chemistry·2026
Same author

Comparative Analysis of High-Throughput Data in AML Detection.

Advances in experimental medicine and biology·2026
Same author

Utilizing Machine Learning for the Identification of Pre-Treatment Prognostic Non-Imaging Biomarkers of Cancer Therapy-Related Cardiac Dysfunction in Female Patients with Breast Cancer<sup></sup>.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Computational Fluid Dynamic Analysis of customized 3D-printed Bone Scaffold based on a Discrete Phase Method.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

In silico Deployment Modeling of an Everolimus Coated Balloon.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025
Same author

Multi-Metric Subgroup Analysis for Glucose Forecasting in Type 1 Diabetes.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2025

Related Experiment Video

Updated: May 29, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K

Optimizing hypoglycaemia prediction in type 1 diabetes with Ensemble Machine Learning modeling.

Daphne N Katsarou1,2, Eleni I Georga2, Maria A Christou3

  • 1Department of Biological Applications and Technology, University of Ioannina, Ioannina, GR45110, Greece.

BMC Medical Informatics and Decision Making
|January 31, 2025
PubMed
Summary
This summary is machine-generated.

This study developed an ensemble model to improve short-term glucose prediction in type 1 diabetes (T1D). The model significantly reduces prediction errors in the hypoglycemic region, aiding better insulin management.

Keywords:
Continuous glucose monitoringGlucose predictionMachine learningType 1 diabetes

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.6K

Related Experiment Videos

Last Updated: May 29, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.7K
Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

18.6K

Area of Science:

  • Endocrinology and Metabolism
  • Biomedical Data Science
  • Machine Learning in Healthcare

Background:

  • Type 1 diabetes (T1D) affects millions globally, necessitating intensive management including insulin therapy and continuous glucose monitoring (CGM).
  • Accurate short-term prediction of subcutaneous glucose levels is crucial for preventing dangerous glucose fluctuations and minimizing long-term complications in T1D patients.

Purpose of the Study:

  • To develop an ensemble univariate predictive model for subcutaneous glucose concentration in T1D.
  • To specifically improve prediction accuracy in the hypoglycemic glucose range.
  • To reduce erroneous predictions (EP) evaluated by continuous glucose error grid analysis (CG-EGA).

Main Methods:

  • An ensemble model was constructed using basis functions selected for minimizing EP in the hypoglycemic region.
  • XGBoost and Support Vector Regression (SVR) were identified as top-performing basis models for the ensemble.
  • The dataset included 29 individuals with T1D, monitored for 2-4 weeks in the GlucoseML study.

Main Results:

  • The ensemble model demonstrated a significant reduction in EP within the hypoglycemic region, achieving 19% error at a 30-minute prediction horizon.
  • This represents a substantial improvement compared to individual basis models like XGBoost and SVR.
  • Overall prediction errors across hypoglycemic, euglycemic, and hyperglycemic ranges remained comparable to the best individual basis models.

Conclusions:

  • Incorporating basis function performance in the hypoglycemic region during ensemble construction enhances joint performance in this critical area.
  • The developed ensemble model offers potential for more precise insulin management in T1D.
  • This approach may lead to a reduced risk of short-term hypoglycemic events.